We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Zevra Therapeutics
ZVRA
$686M
| $220K | ﹤0.01% |
45,721
+2,558
| +6% | +$12.8K |
|
2952
Fidelity D&D Bancorp
FDBC
$317M
| $220K | ﹤0.01% |
4,844
+250
| +5% | +$11.8K |
|
2953
908 Devices
MASS
$364M
| $220K | ﹤0.01% |
32,978
-2,944
| -8% | -$20.4K |
|
2954
Bankwell Financial Group
BWFG
$533M
| $219K | ﹤0.01% |
9,028
+121
| +1% | +$3.14K |
|
2955
Liberty Global Class C
LBTYK
$3.49B
| $219K | ﹤0.01% |
11,798
+14
| +0.1% | +$269 |
|
|
PLGO
2956
Pelagos Insurance Capital
PLGO
$2.14B
| $219K | ﹤0.01% |
+14,897
| New | +$209K |
|
2957
Monte Rosa Therapeutics
GLUE
$1.35B
| $218K | ﹤0.01% |
45,603
+578
| +1% | +$3.72K |
|
2958
Crawford & Co Class A
CRD.A
$669M
| $218K | ﹤0.01% |
23,382
-100
| -0.4% | -$1K |
|
|
TBCH
2959
Turtle Beach Corp
TBCH
$277M
| $218K | ﹤0.01% |
24,027
+1,444
| +6% | +$15.5K |
|
|
PAMT
2960
PAMT Corp
PAMT
$297M
| $217K | ﹤0.01% |
10,082
+226
| +2% | +$5.35K |
|
2961
Atlanticus Holdings
ATLC
$1.52B
| $217K | ﹤0.01% |
7,150
+188
| +3% | +$6.77K |
|
2962
NACCO Industries
NC
$320M
| $216K | ﹤0.01% |
6,169
+44
| +0.7% | +$1.5K |
|
2963
James Hardie Industries
JHX
$17.5B
| $216K | ﹤0.01% |
8,221
+105
| +1% | +$2.97K |
|
2964
Atara Biotherapeutics
ATRA
$76.1M
| $215K | ﹤0.01% |
5,819
+108
| +2% | +$4.81K |
|
2965
Norwood Financial Corp
NWFL
$368M
| $215K | ﹤0.01% |
8,356
+388
| +5% | +$11.1K |
|
2966
Expensify
EXFY
$245M
| $214K | ﹤0.01% |
65,967
+3,621
| +6% | +$19.6K |
|
2967
ArcelorMittal
MT
$55.3B
| $214K | ﹤0.01% |
8,543
| – | – |
|
|
GRTS
2968
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $214K | ﹤0.01% |
124,221
-5,832
| -4% | -$10.4K |
|
2969
Full Truck Alliance
YMM
$9.99B
| $213K | ﹤0.01% |
30,305
-6,375
| -17% | -$44K |
|
2970
EverQuote
EVER
$906M
| $213K | ﹤0.01% |
29,504
-91
| -0.3% | -$593 |
|
2971
Wheaton Precious Metals
WPM
$60.9B
| $213K | ﹤0.01% |
5,251
-88
| -2% | -$3.79K |
|
|
NVTA
2972
DELISTED
Invitae Corporation
NVTA
| $213K | ﹤0.01% |
351,605
+2,963
| +0.8% | +$3.08K |
|
|
ORGN
2973
DELISTED
Origin Materials
ORGN
| $211K | ﹤0.01% |
5,483
+202
| +4% | +$15.9K |
|
|
NJ
2974
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $210K | ﹤0.01% |
18,240
+100
| +0.6% | +$1.15K |
|
2975
CorMedix
CRMD
$584M
| $210K | ﹤0.01% |
56,696
+7,141
| +14% | +$28.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.